Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$185,086
-$461,352 QoQ
Shares Held
1,181
-72.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,326
of 1,603 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ATLAS CAPITAL ADVISORS INC. holds $9,612,551 across 15 Drug Manufacturers - General names. NVS ranks #10 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,869 | $4,640,595 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
7,901 | $998,212 | |
| 3 | MRK |
Merck & Co., Inc.
|
5,216 | $670,256 | |
| 4 | BIIB |
Biogen Inc.
|
2,930 | $633,055 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
10,844 | $624,831 | |
| 6 | AZN |
Astrazeneca PLC
|
2,976 | $564,309 | |
| 7 | AMGN |
Amgen Inc
|
1,185 | $429,112 | |
| 8 | GRFS |
Grifols SA
|
31,637 | $223,989 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $185,086 | 1,181 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $646,438 | 4,232 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $624,826 | 4,532 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $548,417 | 4,532 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $505,227 | 4,532 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $441,008 | 4,532 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $84,194 | 732 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $482,476 | 4,532 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $70,806 | 732 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $567,855 | 5,624 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $409,477 | 4,020 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $405,658 | 4,020 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $369,840 | 4,020 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $364,694 | 4,020 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $318,253 | 4,187 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $609,123 | 7,206 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $1,034,397 | 11,788 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,031,096 | 11,788 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $741,662 | 9,069 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $383,208 | 4,200 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $359,016 | 4,200 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $600,858 | 6,363 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $553,326 | 6,363 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $555,744 | 6,363 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $536,749 | 6,510 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||